0001193125-16-530820 Sample Contracts

KURA ONCOLOGY, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [ ], 20

Common Stock Warrant Agreement • April 5th, 2016 • Kura Oncology, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Common Stock Warrant Agreement
• Filed
  April 5th, 2016
• Company
  Kura Oncology, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between KURA ONCOLOGY, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

KURA ONCOLOGY, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20

Warrant Agreement • April 5th, 2016 • Kura Oncology, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Warrant Agreement
• Filed
  April 5th, 2016
• Company
  Kura Oncology, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between KURA ONCOLOGY, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).

KURA ONCOLOGY, INC. and , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [ ], 20

Preferred Stock Warrant Agreement • April 5th, 2016 • Kura Oncology, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Preferred Stock Warrant Agreement
• Filed
  April 5th, 2016
• Company
  Kura Oncology, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between KURA ONCOLOGY, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).